{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:11:34Z","timestamp":1790172694920,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T00:00:00Z","timestamp":1349740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00415-012-6688-y","type":"journal-article","created":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T06:42:11Z","timestamp":1349678531000},"page":"620-626","source":"Crossref","is-referenced-by-count":84,"title":["Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections"],"prefix":"10.1007","volume":"260","author":[{"given":"Jan Jessen","family":"Krut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cinque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Studahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Gissl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,9]]},"reference":[{"issue":"9533","key":"6688_CR1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer\u2019s disease. Lancet 368(9533):387\u2013403. doi: 10.1016\/S0140-6736(06)69113-7","journal-title":"Lancet"},{"issue":"3","key":"6688_CR2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6(3):131\u2013144. doi: 10.1038\/nrneurol.2010.4","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"6688_CR3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exger.2009.10.010","volume":"45","author":"H Hampel","year":"2010","unstructured":"Hampel H, Blennow K, Shaw LM, Hoessler YC, Zetterberg H, Trojanowski JQ (2010) Total and phosphorylated tau protein as biological markers of Alzheimer\u2019s disease. Exp Gerontol 45(1):30\u201340. doi: 10.1016\/j.exger.2009.10.010","journal-title":"Exp Gerontol"},{"issue":"1","key":"6688_CR4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.exger.2009.08.002","volume":"45","author":"H Zetterberg","year":"2010","unstructured":"Zetterberg H, Blennow K, Hanse E (2010) Amyloid beta and APP as biomarkers for Alzheimer\u2019s disease. Exp Gerontol 45(1):23\u201329. doi: 10.1016\/j.exger.2009.08.002","journal-title":"Exp Gerontol"},{"issue":"4","key":"6688_CR5","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","volume":"60","author":"D Strozyk","year":"2003","unstructured":"Strozyk D, Blennow K, White LR, Launer LJ (2003) CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60(4):652\u2013656","journal-title":"Neurology"},{"issue":"10","key":"6688_CR6","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","volume":"29","author":"A Forsberg","year":"2008","unstructured":"Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, Ringheim A, Langstrom B, Nordberg A (2008) PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 29(10):1456\u20131465. doi: 10.1016\/j.neurobiolaging.2007.03.029","journal-title":"Neurobiol Aging"},{"issue":"3","key":"6688_CR7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","volume":"59","author":"AM Fagan","year":"2006","unstructured":"Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, DeKosky ST, Morris JC, Holtzman DM (2006) Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 59(3):512\u2013519. doi: 10.1002\/ana.20730","journal-title":"Ann Neurol"},{"issue":"4","key":"6688_CR8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/1352458508100031","volume":"15","author":"N Mattsson","year":"2009","unstructured":"Mattsson N, Axelsson M, Haghighi S, Malmestrom C, Wu G, Anckarsater R, Sankaranarayanan S, Andreasson U, Fredrikson S, Gundersen A, Johnsen L, Fladby T, Tarkowski A, Trysberg E, Wallin A, Anckarsater H, Lycke J, Andersen O, Simon AJ, Blennow K, Zetterberg H (2009) Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis. Mult Scler 15(4):448\u2013454. doi: 10.1177\/1352458508100031","journal-title":"Mult Scler"},{"issue":"1\u20132","key":"6688_CR9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(01)02285-6","volume":"314","author":"M Sjogren","year":"2001","unstructured":"Sjogren M, Gisslen M, Vanmechelen E, Blennow K (2001) Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment. Neurosci Lett 314(1\u20132):33\u201336. pii:S0304394001022856","journal-title":"Neurosci Lett"},{"key":"6688_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2377-9-63","volume":"9","author":"M Gisslen","year":"2009","unstructured":"Gisslen M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, Spudich S, Hagberg L, Rosengren L, Price RW, Zetterberg H (2009) Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol 9:63. doi: 10.1186\/1471-2377-9-63","journal-title":"BMC Neurol"},{"issue":"1","key":"6688_CR11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2377-10-51","volume":"10","author":"N Mattsson","year":"2010","unstructured":"Mattsson N, Bremell D, Anckarsater R, Blennow K, Anckarsater H, Zetterberg H, Hagberg L (2010) Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism. BMC Neurol 10(1):51. doi: 10.1186\/1471-2377-10-51","journal-title":"BMC Neurol"},{"issue":"3","key":"6688_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/00365549850160828","volume":"30","author":"M Studahl","year":"1998","unstructured":"Studahl M, Bergstrom T, Hagberg L (1998) Acute viral encephalitis in adults\u2013a prospective study. Scand J Infect Dis 30(3):215\u2013220","journal-title":"Scand J Infect Dis"},{"issue":"8735","key":"6688_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0140-6736(91)92155-U","volume":"337","author":"E Aurelius","year":"1991","unstructured":"Aurelius E, Johansson B, Skoldenberg B, Staland A, Forsgren M (1991) Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet 337(8735):189\u2013192. pii:0140-6736(91)92155-U","journal-title":"Lancet"},{"key":"6688_CR14","unstructured":"Association AP (1987) Diagnostic and statistical manual of mental disorders. 3rd ed, revised edn. American Psychiatric Association, Arlington"},{"issue":"7","key":"6688_CR15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34(7):939\u2013944","journal-title":"Neurology"},{"issue":"6","key":"6688_CR16","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ajmg.b.30668","volume":"147B","author":"M Zetterberg","year":"2008","unstructured":"Zetterberg M, Landgren S, Andersson ME, Palmer MS, Gustafson DR, Skoog I, Minthon L, Thelle DS, Wallin A, Bogdanovic N, Andreasen N, Blennow K, Zetterberg H (2008) Association of complement factor H Y402H gene polymorphism with Alzheimer\u2019s disease. Am J Med Genet B Neuropsychiatr Genet 147B(6):720\u2013726. doi: 10.1002\/ajmg.b.30668","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"18","key":"6688_CR17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789\u20131799. doi: 10.1212\/01.WNL.0000287431.88658.8b","journal-title":"Neurology"},{"key":"6688_CR18","doi-asserted-by":"crossref","unstructured":"American Academy of Neurology AIDS Task Force (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41(6):778\u2013785","DOI":"10.1212\/WNL.41.6.778"},{"key":"6688_CR19","unstructured":"National Center for Infectious Diseases Division of HIV\/AIDS, CDC (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41(RR-17):1\u201319"},{"issue":"1","key":"6688_CR20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","volume":"285","author":"E Vanmechelen","year":"2000","unstructured":"Vanmechelen E (2000) Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett 285(1):49","journal-title":"Neurosci Lett"},{"issue":"3","key":"6688_CR21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","volume":"26","author":"K Blennow","year":"1995","unstructured":"Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E (1995) Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 26(3):231\u2013245. doi: 10.1007\/BF02815140","journal-title":"Mol Chem Neuropathol"},{"key":"6688_CR22","first-page":"773","volume-title":"Fisher A HI","author":"HBK Vanderstichele","year":"1998","unstructured":"Vanderstichele HBK, D\u2019Heuvaert N, Buyse M, Wallin A et al (1998) Development of a specific diagnostic test for measurement of amyloid (1\u201342) beta in CSF. In: Yoshida M (ed) Fisher A HI. Progress in Alzheimer\u2019s and Parkinson\u2019s Diseases. Plenum Press, New York, pp 773\u2013778"},{"issue":"2\u20133","key":"6688_CR23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2007.09.077","volume":"429","author":"MA Wozniak","year":"2007","unstructured":"Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB (2007) Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci Lett 429(2\u20133):95\u2013100. doi: 10.1016\/j.neulet.2007.09.077","journal-title":"Neurosci Lett"},{"key":"6688_CR24","author":"R Piacentini","year":"2010","unstructured":"Piacentini R, Civitelli L, Ripoli C, Marcocci ME, De Chiara G, Garaci E, Azzena GB, Palamara AT, Grassi C (2010) HSV-1 promotes Ca(2+)-mediated APP phosphorylation and Abeta accumulation in rat cortical neurons. Neurobiol Aging. doi: 10.1016\/j.neurobiolaging.2010.06.009","journal-title":"Neurobiol Aging"},{"key":"6688_CR25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2180-5-48","volume":"5","author":"SJ Shipley","year":"2005","unstructured":"Shipley SJ, Parkin ET, Itzhaki RF, Dobson CB (2005) Herpes simplex virus interferes with amyloid precursor protein processing. BMC Microbiol 5:48. doi: 10.1186\/1471-2180-5-48","journal-title":"BMC Microbiol"},{"issue":"3","key":"6688_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0022-510X(84)90173-4","volume":"64","author":"P Livrea","year":"1984","unstructured":"Livrea P, Trojano M, Simone IL, Zimatore GB, Pisicchio L, Logroscino G, Cibelli G (1984) Heterogeneous models for blood-cerebrospinal fluid barrier permeability to serum proteins in normal and abnormal cerebrospinal fluid\/serum protein concentration gradients. J Neurol Sci 64(3):245\u2013258","journal-title":"J Neurol Sci"},{"key":"6688_CR27","first-page":"11","volume":"2010","author":"M Bjerke","year":"2010","unstructured":"Bjerke M, Portelius E, Minthon L, Wallin A, Anckarsater H, Anckarsater R, Andreasen N, Zetterberg H, Andreasson U, Blennow K (2010) Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid. Int J Alzheimer\u2019s Dis 2010:11. doi: 10.4061\/2010\/986310","journal-title":"Int J Alzheimer\u2019s Dis"},{"issue":"3","key":"6688_CR28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1212\/01.WNL.0000106826.82670.30","volume":"62","author":"R Nau","year":"2004","unstructured":"Nau R, Gerber J, Bunkowski S, Bruck W (2004) Axonal injury, a neglected cause of CNS damage in bacterial meningitis. Neurology 62(3):509\u2013511","journal-title":"Neurology"},{"issue":"6","key":"6688_CR29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1474-4422(07)70128-X","volume":"6","author":"AR Pachner","year":"2007","unstructured":"Pachner AR, Steiner I (2007) Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol 6(6):544\u2013552. doi: 10.1016\/S1474-4422(07)70128-X","journal-title":"Lancet Neurol"},{"issue":"2","key":"6688_CR30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0306-4522(96)00577-5","volume":"78","author":"S Lovestone","year":"1997","unstructured":"Lovestone S, Reynolds CH (1997) The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 78(2):309\u2013324. pii:S0306452296005775","journal-title":"Neuroscience"},{"issue":"3","key":"6688_CR31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-2008-14301","volume":"14","author":"A Zambrano","year":"2008","unstructured":"Zambrano A, Solis L, Salvadores N, Cortes M, Lerchundi R, Otth C (2008) Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1. J Alzheimers Dis 14(3):259\u2013269","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"6688_CR32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-2008-13405","volume":"13","author":"RF Itzhaki","year":"2008","unstructured":"Itzhaki RF, Wozniak MA (2008) Herpes simplex virus type 1 in Alzheimer\u2019s disease: the enemy within. J Alzheimers Dis 13(4):393\u2013405","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"6688_CR33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jalz.2008.12.001","volume":"5","author":"K Honjo","year":"2009","unstructured":"Honjo K, van Reekum R, Verhoeff NP (2009) Alzheimer\u2019s disease and infection: do infectious agents contribute to progression of Alzheimer\u2019s disease? Alzheimers Dement 5(4):348\u2013360. doi: 10.1016\/j.jalz.2008.12.001","journal-title":"Alzheimers Dement"},{"issue":"9047","key":"6688_CR34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","volume":"349","author":"RF Itzhaki","year":"1997","unstructured":"Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (1997) Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease. Lancet 349(9047):241\u2013244. doi: 10.1016\/S0140-6736(96)10149-5","journal-title":"Lancet"},{"issue":"3","key":"6688_CR35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.mp.4001220","volume":"8","author":"M Riemenschneider","year":"2003","unstructured":"Riemenschneider M, Wagenpfeil S, Vanderstichele H, Otto M, Wiltfang J, Kretzschmar H, Vanmechelen E, Forstl H, Kurz A (2003) Phospho-tau\/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol Psychiatry 8(3):343\u2013347. doi: 10.1038\/sj.mp.4001220","journal-title":"Mol Psychiatry"},{"issue":"3","key":"6688_CR36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(00)01697-9","volume":"297","author":"C Hesse","year":"2001","unstructured":"Hesse C, Rosengren L, Andreasen N, Davidsson P, Vanderstichele H, Vanmechelen E, Blennow K (2001) Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci Lett 297(3):187\u2013190. pii:S0304394000016979","journal-title":"Neurosci Lett"},{"issue":"23","key":"6688_CR37","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181c5b445","volume":"73","author":"DB Clifford","year":"2009","unstructured":"Clifford DB, Fagan AM, Holtzman DM, Morris JC, Teshome M, Shah AR, Kauwe JS (2009) CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 73(23):1982\u20131987. doi: 10.1212\/WNL.0b013e3181c5b445","journal-title":"Neurology"},{"issue":"9","key":"6688_CR38","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1212\/01.wnl.0000183293.95787.b7","volume":"65","author":"BJ Brew","year":"2005","unstructured":"Brew BJ, Pemberton L, Blennow K, Wallin A, Hagberg L (2005) CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology 65(9):1490\u20131492. doi: 10.1212\/01.wnl.0000183293.95787.b7","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6688-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-012-6688-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6688-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:23:08Z","timestamp":1559071388000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-012-6688-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,9]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["6688"],"URL":"https:\/\/doi.org\/10.1007\/s00415-012-6688-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,9]]}}}